Reset
Showing 20 of 478 academic articles

Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics

Ji Su Hwang, Seok Gi Kim, Tae Hwan Shin, Yong Eun Jang et al. • Pharmaceutics (2022)

Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cance...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14050997

Deep learning in medical imaging and radiation therapy

Berkman Sahiner, Aria X. Pezeshk, Lubomir M. Hadjiiski, Xiaosong Wang et al. • Medical Physics (2018)

The goals of this review paper on deep learning (DL) in medical imaging and radiation therapy are to (a) summarize what has been achieved to date; (b) identify common and unique challenges, and strategies that researchers have taken to addr...

OPENALEX Open Access DOI: https://doi.org/10.1002/mp.13264 PMC: 9560030

Machine Learning and Data Mining Methods in Diabetes Research

Ioannis Kavakiotis, O. Tsave, Athanasios Salifoglou, Nicos Maglaveras et al. • Computational and Structural Biotechnology Journal (2017)

The remarkable advances in biotechnology and health sciences have led to a significant production of data, such as high throughput genetic data and clinical information, generated from large Electronic Health Records (EHRs). To this end, ap...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.csbj.2016.12.005 PMC: 5257026

Machine Learning in Healthcare Communication

Sarkar Siddique, James C. L. Chow • Encyclopedia (2021)

Machine learning (ML) is a study of computer algorithms for automation through experience. ML is a subset of artificial intelligence (AI) that develops computer systems, which are able to perform tasks generally having need of human intelli...

OPENALEX cc-by DOI: https://doi.org/10.3390/encyclopedia1010021

Machine learning in pain research

Jörn Lötsch, Alfred Ultsch • Pain (2017)

1. Introduction Pain and pain chronification are incompletely understood and unresolved medical problems that continue to have a high prevalence.14 It has been accepted that pain is a complex phenomenon.2,32,72 Contemporary methods of compu...

OPENALEX cc-by-nc-nd DOI: https://doi.org/10.1097/j.pain.0000000000001118 PMC: 5895117

Dynamic Monitoring of Thyroid-Stimulating Hormone Receptor Antibody and Extraocular Muscle Thickness: A Clinical Risk Stratification Model for Recurrence Risk Post-Glucocorticoid Therapy in TED Patients

Li Y, Yang X, Hu S • International Journal of General Medicine (2026)

Yaling Li, Xiuhong Yang, Shuli Hu Department of Intensive Care Unit, Wuhan No. 1 Hospital, Wuhan, 430022, People’s Republic of ChinaCorrespondence: Shuli Hu, Department of Intensive Care Unit, Wuhan No. 1 Hospital, No. 215 Zhongshan Avenue,...

DOAJ Open Access (DOAJ)

Artificial intelligence in cancer target identification and drug discovery

Yujie You, Xin Lai, Yi Feng Pan, Huiru Zheng et al. • Signal Transduction and Targeted Therapy (2022)

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems ...

OPENALEX cc-by DOI: https://doi.org/10.1038/s41392-022-00994-0 PMC: 9090746

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies

Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine (2026)

Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12967-026-07966-w

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report

Lars Kurch, Thomas W. Georgi, Astrid Monecke, Daniel Seehofer et al. • Frontiers in Oncology (2022)

A 28-year-old female patient with active and difficult-to-treat systemic lupus erythematosus (SLE) was diagnosed with liver-dominant diffused large B-cell lymphoma. Repeated response 18F-FDG-PET studies showed persistently high, and, despit...

DOAJ Open Access (DOAJ) DOI: 10.3389/fonc.2021.798757

Artificial intelligence in pancreatic cancer

Bowen Huang, Haoran Huang, Shuting Zhang, Dingyue Zhang et al. • Theranostics (2022)

Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%. The pancreatic cancer patients diagnosed with early screening have a median overall survival of nearly ten years, compared with 1.5 years for th...

OPENALEX cc-by DOI: https://doi.org/10.7150/thno.77949 PMC: 9576619

Artificial intelligence in nanomedicine

Dean Ho, Peter Wang, Theodore Wonpeum Kee • Nanoscale Horizons (2018)

The field of nanomedicine has made substantial strides in the areas of therapeutic and diagnostic development. For example, nanoparticle-modified drug compounds and imaging agents have resulted in markedly enhanced treatment outcomes and co...

OPENALEX DOI: https://doi.org/10.1039/c8nh00233a